Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries

Effective and durable options for infrapopliteal artery revascularization for patients with chronic limb-threatening ischemia (CLTI) are limited. The SAVAL trial is a prospective, multicenter, randomized trial of patients with CLTI and infrapopliteal artery lesions with total lesion length ⩽ 140 mm,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Vascular medicine (London, England) Ročník 28; číslo 6; s. 571
Hlavní autoři:	van Overhagen, Hans, Nakamura, Masato, Geraghty, Patrick J, Rao, Sid, Arroyo, Max, Soga, Yoshimitsu, Iida, Osamu, Armstrong, Ehrin, Nakama, Tatsuya, Fujihara, Masahiko, Ansari, Mohammad M, Mathews, Santhosh J, Gouëffic, Yann, Jaff, Michael R, Weinberg, Ido, Pinto, Duane S, Ohura, Norihiko, Couch, Kara, Mustapha, Jihad A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.12.2023
Témata:	Angioplasty, Balloon - adverse effects Drug-Eluting Stents - adverse effects Humans Ischemia - diagnostic imaging Ischemia - therapy Paclitaxel - adverse effects Peripheral Arterial Disease - diagnostic imaging Peripheral Arterial Disease - therapy Popliteal Artery - diagnostic imaging Prospective Studies Stents Treatment Outcome Vascular Patency stent chronic limb-threatening ischemia (CLTI) endovascular therapy peripheral artery disease (PAD)
ISSN:	1477-0377, 1477-0377
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!